Enhanced prereceptor glucocorticoid metabolism and lipogenesis impair insulin signaling in the liver of fructose-fed rats

Journal of Nutritional Biochemistry

Volumn 24, Issue 11, 2013, Pages 1790-1797

  Vasiljević, Ana ^a   Veličković, Nataša ^a   Bursać, Biljana ^a   Djordjevic, Ana ^a   Milutinović, Danijela Vojnović ^a   Nestorović, Nataša ^a   Matić, Gordana ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

11 HSD1; Fructose; Glucocorticoids; Lipogenesis; Liver

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE 1; CORTICOSTERONE; FATTY ACID; FRUCTOSE; GLUCOCORTICOID RECEPTOR; GLUCOSE; GLUCOSE 6 PHOSPHATE DEHYDROGENASE; LIPIN 1; MESSENGER RNA; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); SERINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALORIC INTAKE; CORTICOSTEROID METABOLISM; CYTOPLASM; ENZYME PHOSPHORYLATION; GLUCOSE BLOOD LEVEL; HYPERTRIGLYCERIDEMIA; LIPOGENESIS; LIVER HISTOLOGY; LIVER WEIGHT; MALE; NONHUMAN; RAT; TRIACYLGLYCEROL BLOOD LEVEL;

RATTUS;

11ΒHSD1; FRUCTOSE; GLUCOCORTICOIDS; LIPOGENESIS; LIVER;

11-BETA-HYDROXYSTEROID DEHYDROGENASE TYPE 1; ANIMALS; CARBOHYDRATE DEHYDROGENASES; CORTICOSTERONE; DIETARY CARBOHYDRATES; FRUCTOSE; GLUCOCORTICOIDS; INSULIN; LIPOGENESIS; LIVER; MALE; NUCLEAR PROTEINS; PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP); RATS; RATS, WISTAR; RECEPTORS, GLUCOCORTICOID; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

EID: 84885851340     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2013.04.001     Document Type: Article

References (54)

1. Tappy L., Le K.A. Metabolic effects of fructose and the worldwide increase in obesity. Physiol Rev 2010, 90:23-46.
2. Havel P.J. Dietary fructose: implications for dysregulation of energy homeostasis and lipid/carbohydrate metabolism. Nutr Rev 2005, 63:133-157.
3. Dekker M.J., Su Q., Baker C., Rutledge A.C., Adeli K. Fructose: a highly lipogenic nutrient implicated in insulin resistance, hepatic steatosis, and the metabolic syndrome. Am J Physiol Endocrinol Metab 2010, 299:E685-E694.
4. Huang B.W., Chiang M.T., Yao H.T., Chiang W. The effect of high-fat and high-fructose diets on glucose tolerance and plasma lipid and leptin levels in rats. Diabetes Obes Metab 2004, 6:120-126.
5. Roglans N., Vila L., Farre M., Alegret M., Sanchez R.M., Vazquez-Carrera M., et al. Impairment of hepatic Stat-3 activation and reduction of PPARalpha activity in fructose-fed rats. Hepatology 2007, 45:778-788.
6. Staab C.A., Maser E. 11beta-Hydroxysteroid dehydrogenase type 1 is an important regulator at the interface of obesity and inflammation. J Steroid Biochem Mol Biol 2010, 119:56-72.
7. Wang M. The role of glucocorticoid action in the pathophysiology of the metabolic syndrome. Nutr Metab (Lond) 2005, 2:3.
8. Roberge C., Carpentier A.C., Langlois M.F., Baillargeon J.P., Ardilouze J.L., Maheux P., et al. Adrenocortical dysregulation as a major player in insulin resistance and onset of obesity. Am J Physiol Endocrinol Metab 2007, 293:E1465-E1478.
9. Lottenberg S.A., Giannella-Neto D., Derendorf H., Rocha M., Bosco A., Carvalho S.V., et al. Effect of fat distribution on the pharmacokinetics of cortisol in obesity. Int J Clin Pharmacol Ther 1998, 36:501-505.
10. Walker B.R. Activation of the hypothalamic-pituitary-adrenal axis in obesity: cause or consequence?. Growth Horm IGF Res 2001, 11(Suppl A):S91-S95.
11. Bujalska I.J., Draper N., Michailidou Z., Tomlinson J.W., White P.C., Chapman K.E., et al. Hexose-6-phosphate dehydrogenase confers oxo-reductase activity upon 11 beta-hydroxysteroid dehydrogenase type 1. J Mol Endocrinol 2005, 34:675-684.
12. Czegle I., Csala M., Mandl J., Benedetti A., Karadi I., Banhegyi G. G6PT-H6PDH-11betaHSD1 triad in the liver and its implication in the pathomechanism of the metabolic syndrome. World J Hepatol 2012, 4:129-138.
13. Beato M., Herrlich P., Schutz G. Steroid hormone receptors: many actors in search of a plot. Cell 1995, 83:851-857.
14. Cassuto H., Kochan K., Chakravarty K., Cohen H., Blum B., Olswang Y., et al. Glucocorticoids regulate transcription of the gene for phosphoenolpyruvate carboxykinase in the liver via an extended glucocorticoid regulatory unit. J Biol Chem 2005, 280:33873-33884.
15. Manmontri B., Sariahmetoglu M., Donkor J., Bou Khalil M., Sundaram M., Yao Z., et al. Glucocorticoids and cyclic AMP selectively increase hepatic lipin-1 expression, and insulin acts antagonistically. J Lipid Res 2008, 49:1056-1067.
16. Yadav H., Jain S., Yadav M., Sinha P.R., Prasad G.B., Marotta F. Epigenomic derangement of hepatic glucose metabolism by feeding of high fructose diet and its prevention by Rosiglitazone in rats. Dig Liver Dis 2009, 41:500-508.
17. Watts L.M., Manchem V.P., Leedom T.A., Rivard A.L., McKay R.A., Bao D., et al. Reduction of hepatic and adipose tissue glucocorticoid receptor expression with antisense oligonucleotides improves hyperglycemia and hyperlipidemia in diabetic rodents without causing systemic glucocorticoid antagonism. Diabetes 2005, 54:1846-1853.
18. Stanhope K.L., Havel P.J. Fructose consumption: potential mechanisms for its effects to increase visceral adiposity and induce dyslipidemia and insulin resistance. Curr Opin Lipidol 2008, 19:16-24.
19. Bou Khalil M., Blais A., Figeys D., Yao Z. Lipin - The bridge between hepatic glycerolipid biosynthesis and lipoprotein metabolism. Biochim Biophys Acta 1801, 2010:1249-1259.
20. Bou Khalil M., Sundaram M., Zhang H.Y., Links P.H., Raven J.F., Manmontri B., et al. The level and compartmentalization of phosphatidate phosphatase-1 (lipin-1) control the assembly and secretion of hepatic VLDL. J Lipid Res 2009, 50:47-58.
21. Ryu D., Oh K.J., Jo H.Y., Hedrick S., Kim Y.N., Hwang Y.J., et al. TORC2 regulates hepatic insulin signaling via a mammalian phosphatidic acid phosphatase, LIPIN1. Cell Metab 2009, 9:240-251.
22. Yu C., Chen Y., Cline G.W., Zhang D., Zong H., Wang Y., et al. Mechanism by which fatty acids inhibit insulin activation of insulin receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in muscle. J Biol Chem 2002, 277:50230-50236.
23. Wei Y., Pagliassotti M.J. Hepatospecific effects of fructose on c-jun NH2-terminal kinase: implications for hepatic insulin resistance. Am J Physiol Endocrinol Metab 2004, 287:E926-E933.
24. Duncombe W.G. The colorimetric micro-determination of non-esterified fatty acids in plasma. Clin Chim Acta 1964, 9:122-125.
25. Spector T. Refinement of the coomassie blue method of protein quantitation. A simple and linear spectrophotometric assay for less than or equal to 0.5 to 50 microgram of protein. Anal Biochem 1978, 86:142-146.
26. Djordjevic A., Vojnovic Milutinovic D., Tanic N., Bursac B., Vasiljevic A., Velickovic N., et al. Identification of suitable reference genes for gene expression studies in tissues from fructose-fed rats. Adv Sci Lett 2012, 5:560-565.
27. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
28. Bursać B., Djordjevic A., Vasiljević A., Vojnović Milutinović D., Veličković N., Nestorović N., et al. Fructose consumption enhances glucocorticoid action in rat visceral adipose tissue. J Nutr Biochem 2013, 24:1166-1172.
29. Gross L.S., Li L., Ford E.S., Liu S. Increased consumption of refined carbohydrates and the epidemic of type 2 diabetes in the United States: an ecologic assessment. Am J Clin Nutr 2004, 79:774-779.
30. Kelley G.L., Allan G., Azhar S. High dietary fructose induces a hepatic stress response resulting in cholesterol and lipid dysregulation. Endocrinology 2004, 145:548-555.
31. Seckl J.R., Walker B.R. Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action. Endocrinology 2001, 142:1371-1376.
32. Ahmed A., Saksena S., Sherlock M., Olliff S.P., Elias E., Stewart P.M. Induction of hepatic 11beta-hydroxysteroid dehydrogenase type 1 in patients with alcoholic liver disease. Clin Endocrinol (Oxf) 2008, 68:898-903.
33. Johnstone A.M., Faber P., Andrew R., Gibney E.R., Elia M., Lobley G., et al. Influence of short-term dietary weight loss on cortisol secretion and metabolism in obese men. Eur J Endocrinol 2004, 150:185-194.
34. Stimson R.H., Walker B.R. Glucocorticoids and 11beta-hydroxysteroid dehydrogenase type 1 in obesity and the metabolic syndrome. Minerva Endocrinol 2007, 32:141-159.
35. Livingstone D.E., Jones G.C., Smith K., Jamieson P.M., Andrew R., Kenyon C.J., et al. Understanding the role of glucocorticoids in obesity: tissue-specific alterations of corticosterone metabolism in obese Zucker rats. Endocrinology 2000, 141:560-563.
36. Liu Y., Nakagawa Y., Wang Y., Li R., Li X., Ohzeki T., et al. Leptin activation of corticosterone production in hepatocytes may contribute to the reversal of obesity and hyperglycemia in leptin-deficient ob/ob mice. Diabetes 2003, 52:1409-1416.
37. Aoki K., Homma M., Hirano T., Oka K., Satoh S., Mukasa K., et al. MRNA and enzyme activity of hepatic 11beta-hydroxysteroid dehydrogenase type 1 are elevated in C57BL/KsJ-db/db mice. Life Sci 2001, 69:2543-2549.
38. Liu Y., Nakagawa Y., Wang Y., Sakurai R., Tripathi P.V., Lutfy K., et al. Increased glucocorticoid receptor and 11{beta}-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db/db mice. Diabetes 2005, 54:32-40.
39. London E., Castonguay T.W. High fructose diets increase 11beta-hydroxysteroid dehydrogenase type 1 in liver and visceral adipose in rats within 24-h exposure. Obesity (Silver Spring) 2011, 19:925-932.
40. Drake A.J., Livingstone D.E., Andrew R., Seckl J.R., Morton N.M., Walker B.R. Reduced adipose glucocorticoid reactivation and increased hepatic glucocorticoid clearance as an early adaptation to high-fat feeding in Wistar rats. Endocrinology 2005, 146:913-919.
41. Alberts P., Ronquist-Nii Y., Larsson C., Klingstrom G., Engblom L., Edling N., et al. Effect of high-fat diet on KKAy and ob/ob mouse liver and adipose tissue corticosterone and 11-dehydrocorticosterone concentrations. Horm Metab Res 2005, 37:402-407.
42. Ahmed A., Rabbitt E., Brady T., Brown C., Guest P., Bujalska I.J., et al. A switch in hepatic cortisol metabolism across the spectrum of non alcoholic fatty liver disease. PLoS One 2012, 7:e29531.
43. Berthiaume M., Laplante M., Festuccia W.T., Cianflone K., Turcotte L.P., Joanisse D.R., et al. 11beta-HSD1 inhibition improves triglyceridemia through reduced liver VLDL secretion and partitions lipids toward oxidative tissues. Am J Physiol Endocrinol Metab 2007, 293:E1045-E1052.
44. Paterson J.M., Morton N.M., Fievet C., Kenyon C.J., Holmes M.C., Staels B., et al. Metabolic syndrome without obesity: hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice. Proc Natl Acad Sci U S A 2004, 101:7088-7093.
45. Guo Y., Xiao P., Lei S., Deng F., Xiao G.G., Liu Y., et al. How is mRNA expression predictive for protein expression? A correlation study on human circulating monocytes. Acta Biochim Biophys Sin (Shanghai) 2008, 40:426-436.
46. Veličković N., Djordjevic D., Vasiljević A., Bursać B., Vojnović Milutinović D., Matic G. Tissue-specific regulation of inflammation by macrophage migration inhibitory factor and glucocorticoids in fructose-fed Wistar rats. Br J Nutr 2012, 10.1017/S0007114512005193.
47. Adcock I.M., Caramori G. Cross-talk between pro-inflammatory transcription factors and glucocorticoids. Immunol Cell Biol 2001, 79:376-384.
48. Axelsen L.N., Lademann J.B., Petersen J.S., Holstein-Rathlou N.H., Ploug T., Prats C., et al. Cardiac and metabolic changes in long-term high fructose-fat fed rats with severe obesity and extensive intramyocardial lipid accumulation. Am J Physiol Regul Integr Comp Physiol 2010, 298:R1560-R1570.
49. Feingold K.R., Moser A., Shigenaga J.K., Grunfeld C. Inflammation inhibits the expression of phosphoenolpyruvate carboxykinase in liver and adipose tissue. Innate Immun 2012, 18:231-240.
50. Basciano H., Federico L., Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond) 2005, 2:5.
51. Fabbrini E., Magkos F., Mohammed B.S., Pietka T., Abumrad N.A., Patterson B.W., et al. Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci U S A 2009, 106:15430-15435.
52. Donnelly R., Reed M.J., Azhar S., Reaven G.M. Expression of the major isoenzyme of protein kinase-C in skeletal muscle, nPKC theta, varies with muscle type and in response to fructose-induced insulin resistance. Endocrinology 1994, 135:2369-2374.
53. Vila L., Roglans N., Alegret M., Sanchez R.M., Vazquez-Carrera M., Laguna J.C. Suppressor of cytokine signaling-3 (SOCS-3) and a deficit of serine/threonine (Ser/Thr) phosphoproteins involved in leptin transduction mediate the effect of fructose on rat liver lipid metabolism. Hepatology 2008, 48:1506-1516.
54. Kawasaki T., Igarashi K., Koeda T., Sugimoto K., Nakagawa K., Hayashi S., et al. Rats fed fructose-enriched diets have characteristics of nonalcoholic hepatic steatosis. J Nutr 2009, 139:2067-2071.